Lipocine Inc.
NASDAQ:LPCN
4.61 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| -2.851 | 0.5 | 16.141 | 0 | 0.165 | 0.428 | 0 | 0 | 0 | 0 | 0 | 7.71 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.281 | 0 |
| Gross Profit
| -2.851 | 0.5 | 16.141 | 0 | 0.165 | 0.428 | 0 | 0 | 0 | 0 | 0 | 5.428 | 0 |
| Gross Profit Ratio
| 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0.704 | 0 |
| Reseach & Development Expenses
| 10.175 | 8.557 | 7.666 | 9.748 | 7.468 | 6.465 | 11.004 | 8.076 | 12.58 | 15.479 | 5.591 | 3.04 | 0 |
| General & Administrative Expenses
| 4.905 | 4.062 | 5.33 | 8.248 | 5.597 | 5.289 | 10.214 | 10.382 | 5.802 | 5.001 | 3.636 | 1.551 | 0.005 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.905 | 4.062 | 5.33 | 8.248 | 5.597 | 5.289 | 10.214 | 10.382 | 5.802 | 5.001 | 3.636 | 1.551 | 0.005 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.867 | 11.803 | 16.639 | 20.654 | 12.829 | 12.087 | 20.982 | 18.971 | 18.382 | 20.481 | 10.684 | 1.551 | 0.005 |
| Operating Income
| -17.931 | -12.119 | 3.146 | -17.996 | -12.9 | -11.326 | -21.218 | -18.458 | -18.382 | -20.481 | -8.759 | 3.877 | -0.005 |
| Operating Income Ratio
| 6.29 | -24.239 | 0.195 | 0 | -78.188 | -26.46 | 0 | 0 | 0 | 0 | 0 | 0.503 | 0 |
| Total Other Income Expenses Net
| 1.58 | 1.361 | -3.78 | -2.968 | -0.107 | -0.334 | 0.236 | -0.513 | 0.174 | 0.108 | -1.887 | 0.01 | 0 |
| Income Before Tax
| -16.351 | -10.758 | -0.634 | -20.965 | -13.007 | -11.659 | -20.982 | -18.971 | -18.208 | -20.372 | -10.645 | 3.888 | -0.005 |
| Income Before Tax Ratio
| 5.736 | -21.516 | -0.039 | 0 | -78.836 | -27.239 | 0 | 0 | 0 | 0 | 0 | 0.504 | 0 |
| Income Tax Expense
| 0.001 | 0.001 | 0 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0.055 | 0.001 | 0 |
| Net Income
| -16.352 | -10.759 | -0.634 | -20.965 | -13.007 | -11.66 | -20.983 | -18.972 | -18.208 | -20.373 | -10.59 | 3.802 | -0.005 |
| Net Income Ratio
| 5.736 | -21.517 | -0.039 | 0 | -78.837 | -27.241 | 0 | 0 | 0 | 0 | 0 | 0.493 | 0 |
| EPS
| -3.14 | -2.15 | -0.19 | -6.46 | -8.54 | -9.35 | -17.79 | -17.66 | -18.79 | -27.13 | -24.45 | 14.5 | -2.93 |
| EPS Diluted
| -3.1 | -2.05 | -0.12 | -6.4 | -8.54 | -9.28 | -17.85 | -17.68 | -18.87 | -27.2 | -24.48 | 14.45 | -2.93 |
| EBITDA
| -17.902 | -12.11 | 3.146 | -17.993 | -12.885 | -11.307 | -21.19 | -18.426 | -18.355 | -20.466 | -8.737 | 3.92 | -0.005 |
| EBITDA Ratio
| 6.28 | -24.22 | 0.195 | 0 | -78.095 | -26.417 | 0 | 0 | 0 | 0 | 0 | 0.508 | 0 |